Combination therapy for rheumatoid arthritis

Research output: Contribution to journalReview article

Abstract

Traditionally, NSAIDs have been used in the initial treatment of patients with rheumatoid arthritis (RA). If the patient's disease progressed, then therapy was "stepped up" to use disease-modifying antirheumatic drugs (DMARDs). However, NSAIDs rarely provide appropriate monotherapy in established RA. Corticosteroids provide relief of symptoms, but they have several adverse effects. Initiation ofDMARD therapy early in the disease course has gained acceptance. Because the RA disease process has many inflammatory and proliferative pathways, multiple agents targeted at specific aspects of the immune response may provide effective therapy without increasing toxicity. Methotrexate is included in most regimens. Hydroxychloroquine and sulfasalazine are commonly used. Newer drugs that may be used in combination therapy include biologic response modifiers that target specific cytokines.

Original languageEnglish (US)
Pages (from-to)36-40
Number of pages5
JournalDrug Benefit Trends
Volume15
Issue numberSUPPL. C
StatePublished - Jun 1 2003

Fingerprint

Rheumatoid Arthritis
Non-Steroidal Anti-Inflammatory Agents
Hydroxychloroquine
Sulfasalazine
Biological Therapy
Antirheumatic Agents
Therapeutics
Methotrexate
Adrenal Cortex Hormones
Cytokines
Pharmaceutical Preparations

Keywords

  • Combination therapy
  • Corticosteroids
  • DMARDs
  • NSAIDs
  • Rheumatoid arthritis

ASJC Scopus subject areas

  • Health Policy
  • Pharmacology (medical)

Cite this

Combination therapy for rheumatoid arthritis. / Cannella, Amy C; O'Dell, James Robert.

In: Drug Benefit Trends, Vol. 15, No. SUPPL. C, 01.06.2003, p. 36-40.

Research output: Contribution to journalReview article

@article{55e778d5544049f792521fcbb969a7a8,
title = "Combination therapy for rheumatoid arthritis",
abstract = "Traditionally, NSAIDs have been used in the initial treatment of patients with rheumatoid arthritis (RA). If the patient's disease progressed, then therapy was {"}stepped up{"} to use disease-modifying antirheumatic drugs (DMARDs). However, NSAIDs rarely provide appropriate monotherapy in established RA. Corticosteroids provide relief of symptoms, but they have several adverse effects. Initiation ofDMARD therapy early in the disease course has gained acceptance. Because the RA disease process has many inflammatory and proliferative pathways, multiple agents targeted at specific aspects of the immune response may provide effective therapy without increasing toxicity. Methotrexate is included in most regimens. Hydroxychloroquine and sulfasalazine are commonly used. Newer drugs that may be used in combination therapy include biologic response modifiers that target specific cytokines.",
keywords = "Combination therapy, Corticosteroids, DMARDs, NSAIDs, Rheumatoid arthritis",
author = "Cannella, {Amy C} and O'Dell, {James Robert}",
year = "2003",
month = "6",
day = "1",
language = "English (US)",
volume = "15",
pages = "36--40",
journal = "Drug Benefit Trends",
issn = "1080-5826",
publisher = "Cliggott Publishing Co.",
number = "SUPPL. C",

}

TY - JOUR

T1 - Combination therapy for rheumatoid arthritis

AU - Cannella, Amy C

AU - O'Dell, James Robert

PY - 2003/6/1

Y1 - 2003/6/1

N2 - Traditionally, NSAIDs have been used in the initial treatment of patients with rheumatoid arthritis (RA). If the patient's disease progressed, then therapy was "stepped up" to use disease-modifying antirheumatic drugs (DMARDs). However, NSAIDs rarely provide appropriate monotherapy in established RA. Corticosteroids provide relief of symptoms, but they have several adverse effects. Initiation ofDMARD therapy early in the disease course has gained acceptance. Because the RA disease process has many inflammatory and proliferative pathways, multiple agents targeted at specific aspects of the immune response may provide effective therapy without increasing toxicity. Methotrexate is included in most regimens. Hydroxychloroquine and sulfasalazine are commonly used. Newer drugs that may be used in combination therapy include biologic response modifiers that target specific cytokines.

AB - Traditionally, NSAIDs have been used in the initial treatment of patients with rheumatoid arthritis (RA). If the patient's disease progressed, then therapy was "stepped up" to use disease-modifying antirheumatic drugs (DMARDs). However, NSAIDs rarely provide appropriate monotherapy in established RA. Corticosteroids provide relief of symptoms, but they have several adverse effects. Initiation ofDMARD therapy early in the disease course has gained acceptance. Because the RA disease process has many inflammatory and proliferative pathways, multiple agents targeted at specific aspects of the immune response may provide effective therapy without increasing toxicity. Methotrexate is included in most regimens. Hydroxychloroquine and sulfasalazine are commonly used. Newer drugs that may be used in combination therapy include biologic response modifiers that target specific cytokines.

KW - Combination therapy

KW - Corticosteroids

KW - DMARDs

KW - NSAIDs

KW - Rheumatoid arthritis

UR - http://www.scopus.com/inward/record.url?scp=0038383471&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038383471&partnerID=8YFLogxK

M3 - Review article

AN - SCOPUS:0038383471

VL - 15

SP - 36

EP - 40

JO - Drug Benefit Trends

JF - Drug Benefit Trends

SN - 1080-5826

IS - SUPPL. C

ER -